Conway DS[au] - Search Results

Year	Number of Results
1986	1
2000	1
2001	5
2002	3
2003	4
2004	7
2005	2
2006	1
2010	2
2012	1
2014	2
2015	2
2016	3
2017	4
2018	2
2019	3
2020	9
2021	6
2022	2

1

Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis.

Chaudhry BZ, Cohen JA, Conway DS. Chaudhry BZ, et al. Among authors: conway ds. Neurotherapeutics. 2017 Oct;14(4):859-873. doi: 10.1007/s13311-017-0565-4. Neurotherapeutics. 2017. PMID: 28812220 Free PMC article. Review.

2

Comorbidities require special attention in minorities with multiple sclerosis.

Conway DS, Marck CH. Conway DS, et al. Mult Scler. 2021 Oct;27(12):1811-1813. doi: 10.1177/13524585211037578. Epub 2021 Aug 27. Mult Scler. 2021. PMID: 34449300 No abstract available.

3

Age of hypertension onset in multiple sclerosis patients.

Briggs FB, Krill D, Hill E, Conway DS. Briggs FB, et al. Among authors: conway ds. Mult Scler. 2021 Nov;27(13):2108-2111. doi: 10.1177/13524585211003016. Epub 2021 Mar 18. Mult Scler. 2021. PMID: 33733922

4

Multiple Sclerosis: Unprecedented Progress But Significant Challenges Ahead.

Conway DS, Hua LH, Cohen JA. Conway DS, et al. Neurotherapeutics. 2017 Oct;14(4):832-834. doi: 10.1007/s13311-017-0576-1. Neurotherapeutics. 2017. PMID: 28956322 Free PMC article. No abstract available.

5

What is the impact of socioeconomic status on multiple sclerosis?

Conway DS. Conway DS. Neurology. 2019 Mar 26;92(13):e1536-e1539. doi: 10.1212/WNL.0000000000007166. Neurology. 2019. PMID: 30910951 No abstract available.

6

Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthma.

Sorensen A, Conway DS, Briggs FBS. Sorensen A, et al. Among authors: conway ds. Mult Scler Relat Disord. 2021 Aug;53:103040. doi: 10.1016/j.msard.2021.103040. Epub 2021 May 21. Mult Scler Relat Disord. 2021. PMID: 34058603

7

Antithrombotic therapy for atrial fibrillation.

Lip GY, Hart RG, Conway DS. Lip GY, et al. Among authors: conway ds. BMJ. 2002 Nov 2;325(7371):1022-5. doi: 10.1136/bmj.325.7371.1022. BMJ. 2002. PMID: 12411366 Free PMC article. Review. No abstract available.

8

Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis.

Conway DS, Thompson NR, Meng X, Johnson K, Fox RJ. Conway DS, et al. Mult Scler. 2021 Apr;27(5):742-754. doi: 10.1177/1352458520936214. Epub 2020 Jul 16. Mult Scler. 2021. PMID: 32672101

9

Technology-enabled assessments to enhance multiple sclerosis clinical care and research.

Macaron G, Moss BP, Li H, Baldassari LE, Rao SM, Schindler D, Alberts JL, Weber M, Ayers M, Bethoux F, Boissy A, Chizmadia D, Conway DS, Fink C, Fox RJ, Gales S, Green B, Hara-Cleaver C, Jordan N, Mahajan KR, McGinley MP, Miller DM, Namey M, Rae-Grant A, Rensel M, Young H, Willis MA, Ontaneda D, Cohen JA, Bermel RA. Macaron G, et al. Among authors: conway ds. Neurol Clin Pract. 2020 Jun;10(3):222-231. doi: 10.1212/CPJ.0000000000000710. Neurol Clin Pract. 2020. PMID: 32642324 Free PMC article.

10

Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice.

Baldassari LE, Nakamura K, Moss BP, Macaron G, Li H, Weber M, Jones SE, Rao SM, Miller D, Conway DS, Bermel RA, Cohen JA, Ontaneda D, McGinley MP. Baldassari LE, et al. Among authors: conway ds. Mult Scler Relat Disord. 2020 Feb;38:101525. doi: 10.1016/j.msard.2019.101525. Epub 2019 Nov 14. Mult Scler Relat Disord. 2020. PMID: 31759186 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results